Shilpa Medicare reports Q3 earnings –
Key Financial Highlights (Q3 FY25):
- Net Profit: ₹32 crore, a significant increase compared to ₹4.6 crore in Q3 FY24, marking a strong turnaround.
- Revenue: ₹319 crore, up 11% from ₹287 crore YoY, driven by increased demand across key product categories.
- EBITDA: ₹81 crore, up 21.4% from ₹66.4 crore YoY, indicating operational efficiency improvements.
- EBITDA Margin: Improved to 25.2% from 23% YoY, showcasing effective cost management.
Shilpa Medicare plans to sustain growth through product innovation and geographical expansion, targeting further margin improvement. However, the company remains watchful of potential cost pressures.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your research or consult a financial advisor before making investment decisions.
